| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.6 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.039 | 0.6 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |